Drug intelligence / Profile preview

sodium citrate + ethanol

Development stage
Preclinical
Lead developer
Dirinco
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Sodium citrate + ethanol** is a sterile, single-use catheter-lock solution containing 4% sodium citrate and 30% ethanol, marketed as **CitraFlow PLUS** and regionally as **CitraLok PLUS**. It is instilled into the lumen of an indwelling vascular-access or hemodialysis catheter between treatments rather than administered as a systemic infusion. Citrate chelates ionized calcium to inhibit calcium-dependent coagulation within the catheter, helping maintain patency and prevent thrombosis, while ethanol provides broad local antimicrobial activity and may reduce intraluminal biofilm formation. A University of Manitoba randomized pilot study evaluated the 30% ethanol/4% sodium citrate lock versus heparin for prevention of catheter-related infection, bacteremia, and thrombosis in patients with stage V chronic kidney disease receiving hemodialysis.

Brand names
CitraFlow PLUSCitraLok PLUS
Other names
30% ethanol + 4% sodium citrate catheter locking solutionCitra Lok Plusethanol + sodium citrate catheter locking solutionsodium citrate 4% + ethanol 30%

Beyond the preview

Go deeper on sodium citrate + ethanol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium citrate + ethanol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call